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Purpose: To evaluate the long-term structural and functional outcome in patients with multiple 
sclerosis (MS) with and without a history of optic neuritis (ON).
Methods: This was a cross-sectional study of 82 patients diagnosed with MS between 2000 
and 2006 from a tertiary hospital center in Denmark. Patients gave a self-reported history of ON, 
and functional (visual acuity and color vision) and structural (spectra domain optical coherence 
tomography) markers of vision were tested.
Results: Median age and MS duration at the time of the clinical examination were 49.9 years 
(range 30.7–72.6 years) and 13 years (range 9–15 years), respectively. ON was not associated 
with impairment of visual acuity or color vision. Twenty-three patients had a history of ON in 
at least one eye. Compared to non-affected patients, these had a lower inferior (109 vs 113 µm, 
P=0.04) and temporal retinal nerve fiber layer (RNFL) thickness (56 vs 67 µm, P=0.01). In an 
age- and sex-adjusted logistic regression model, lower inferior and temporal RNFL were associ-
ated with a higher risk of ON (odds ratio [OR] 1.56 [95% confidence interval {CI} 1.01–2.41] 
and OR 1.74 [95% CI 1.10–2.77] per 10 µm decrement in RNFL thickness, respectively). 
Twenty patients had a history of ON in one eye. Compared to the non-affected eye, this eye 
had a lower RNFL (109 vs 115 µm, P=0.04) and a higher central retinal thickness/mean RNFL 
ratio (2.7 vs 2.4, P=0.04).
Conclusion: Although patients with long-term MS and a previous history of ON did not 
have any functional loss of vision, structural neurodegeneration could be demonstrated in the 
affected eye.
Keywords: optic neuritis, multiple sclerosis, optical coherence tomography, retinal nerve fiber 
layer, central retinal thickness
Introduction
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the 
central nervous system (CNS), which results in axonal degeneration.1 Optic neuritis 
(ON) is an inflammatory demyelinating disease of the optic nerve and the presenting 
symptom in 20% of MS patients.2 About 40% of patients will develop ON during 
the course of MS.2 Recovery after ON is often incomplete with at least one-third of 
patients having persistent visual symptoms, which may lead to a reduced quality of 
life.3 ON is characterized by subacute, unilateral visual loss accompanied by pain in 
the majority of patients but without systemic symptoms.4 The presentation is mostly 
monophasic and unilateral, but it can also be simultaneously bilateral with recurrent 
relapses. In such cases, rare demyelinating inflammatory diseases of the CNS should 
be considered besides MS, such as neuromyelitis optica spectrum disorders (NMODS) 
caused by antibodies against aquaporin 4, anti-myelin oligodendrocyte glycoprotein 
(MOG) disease, and chronic relapsing inflammatory ON.5–7
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As a part of the CNS, the retina opens a window to evalu-
ate unmyelinated axons and status of neurodegeneration 
by optical coherence tomography (OCT). Thinning of the 
peripapillary retinal nerve fiber layer (RNFL) around the 
optic disc has been demonstrated after ON, and even in 
the absence of ON, patients with MS may have progressive 
RNFL loss over time.8
Previous studies have proposed the use of OCT to differ-
entiate MS subtypes, to evaluate disease activity, or to esti-
mate the efficacy of neuroprotective treatment.8–11 However, 
most OCT data in ON are based on small cohorts,12–14 patients 
with acute ON,15 or reflect short-term changes.8,11–13,16–18 
In addition, some studies are based on low-resolution time 
domain (TD) OCT.8,18
Long-term data of high-resolution spectral domain (SD) 
OCT changes in MS are limited, and hence, the aim of this 
study was to evaluate enduring changes in a clinical cohort 
of MS patients in eyes with and without ON.
Materials and methods
study population
This cross-sectional study prospectively enrolled 89 
patients from a tertiary hospital center in Denmark (Odense 
University Hospital), who were diagnosed with MS accord-
ing to the McDonald criteria between January 1, 2000, and 
December 31, 2006.19 There were no patients with glaucoma.
The study was performed in accordance with the criteria 
of the Declaration of Helsinki II and was approved by the 
local scientific ethics committee (The Regional Committees 
on Health Research Ethics for Southern Denmark). Written 
informed consent was obtained from all individual partici-
pants included in the study.
Clinical examination
Information of self-reported episodes of ON was collected 
along with the information of which eye had been affected.
Based on the patients’ own refraction, visual acuity was 
tested based on an Early Treatment Diabetic Retinopathy 
Study (ETDRS) standardized testing chart and given as 
numbers of ETDRS letters. Color vision was tested on both 
eyes independently by an Ishihara Color Vision test and 
presented as number of errors. Intraocular eye pressure was 
measured in each eye using an Icare TA01 tonometer (Icare 
Finland Oy, Helsinki, Finland).
A Topcon 3D OCT-2000 spectral domain OCT (Topcon, 
Tokyo, Japan) was used by a trained grader, and the central 
retinal thickness (CRT) and RNFL thickness were mea-
sured. For RNFL, measurements were performed around 
the optic disc in each quadrant (superior, inferior, temporal, 
and nasal).
Patients were asked and hospital databases were reviewed 
for history of ON. In the absence of hospital information, 
ON was defined as subacute visual loss lasting for more than 
24 hours in the presence of absence of pain, deterioration of 
color vision, and treatment with corticosteroid.
statistical analyses
Continuous data are presented as median (with range) and 
categorical as percent. Based on RNFL thickness in all four 
quadrants, we calculated RNFL
mean
 and subsequently the 
CRT/RNFL
mean
 ratio.
Intraindividual differences in continuous values between 
the two eyes were tested with Wilcoxon signed-rank test. 
In patients with a history of no or bilateral ON, mean values 
were calculated between right and left eye for visual acuity, 
Ishihara errors, intraocular pressure, CRT, RNFL, and 
RNFL
mean
. Differences between patients with and without a 
history of self-reported ON were tested with Kruskal–Wallis 
rank test by ranks. A linear regression model was used to 
test for the association between OCT features (independent 
variable) and history of ON (dependent variable) in an 
unadjusted and an age- and-sex-adjusted model. For regres-
sion analysis, we included parameters with P-values ,0.1 
(RNFL
inferior
, RNFL
temporal
, and RNFL
mean
) from the univariate 
model in Table 1. Odds ratio (OR) (with 95% confidence 
interval [CI]) of a self-reported history of ON was given per 
10 µm decrement in RNFL thickness. The P-values ,0.05 
were considered statistically significant.
Stata 14 (StataCorp LP, College Station, TX, USA) was 
used for statistical analyses.
Results
In 82 patients of 89, both eyes were examined by OCT. Of 
those with bilateral OCT, median age at the clinical exami-
nation and time since onset of ON were 49.9 years (range 
30.7–72.6 years) and 13 years (range 9–15 years), respec-
tively. Of the patients, 30.5% were male. Median values of 
right and left eye were 228 and 232 µm for CRT and 90.6 
and 92.4 µm for RNFL
mean
. CRT/RNFL
mean
 ratio for right 
and left eye was 2.6 and 2.5, respectively. Sixty-seven of the 
82 patients (81.7%) were able to provide information about 
history and lateralization of ON.
Twenty patients had at least one episode of unilateral ON 
and were able to identify which eye had been affected. Median 
age of these patients was 47.1 years (range 39.0–62.8 years), 
and 40.0% were male (Table 2). There were no differences 
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between the two eyes regarding visual acuity, Ishihara 
Color Vision test, intraocular pressure, and CRT or RNFL 
in superior, temporal, and nasal quadrant. On the other hand, 
patients had a lower inferior RNFL (109 vs 115 µm, P=0.04) 
and a higher CRT/RNFL
mean
 ratio (2.7 vs 2.4, P=0.04) in the 
affected eye. In addition, there was a trend toward a lower 
mean RNFL in the affected eye (87 vs 93 µm, P=0.06).
Twenty-three patients had a history of ON in at least 
one eye (Figure 1). These patients were compared with the 
44 patients without any episodes of ON. Patients with ON 
had a lower inferior (109 vs 113 µm, P=0.04) and temporal 
(56 vs 67 µm, P=0.01) RNFL in the affected eye (Table 1). 
There was also a trend toward a shorter time since onset of 
MS (12 vs 13 years, P=0.08) and a lower mean RNFL in 
patients with a history of ON (87 vs 92 µm, P=0.07), but 
patients did not differ on other parameters.
In an unadjusted logistic regression model, lower inferior, 
temporal, and mean RNFL thickness were all statistically 
significantly associated with a history of ON (OR 1.63 
[95% CI 1.09–2.46], OR 1.79 [95% CI 1.39–2.80], and 
Table 1 Differences between patients with and without history of self-reported On
Eye with history of ON P-value
Yes No
number 23 44
age (years) 49.3 (39.0–62.8) 50.0 (33.1–72.6) 0.72
sex (% male) 39.1 22.7 0.16
Time since onset of Ms (years) 12 (9–15) 13 (9–15) 0.08
Visual acuity (eTDrs letters) 87 (63–93) 86 (76–93) 0.50
ishihara (number of errors) 0 (0–16) 0 (0–16) 0.50
intraocular pressure (mmhg) 15 (7–26) 15 (10–23) 0.82
CrT (µm) 228 (199–274) 230 (179–290) 0.46
rnFl
superior (µm) 111 (74–124) 108 (70–142) 0.39
inferior (µm) 109 (73–131) 113 (91–150) 0.04*
Temporal (µm) 56 (32–84) 67 (43–95) 0.01*
nasal (µm) 83 (56–115) 81 (54–101) 0.90
Mean (µm) 87 (61–105) 92 (70–113) 0.07
CrT/rnFlmean ratio 2.6 (2.0–3.8) 2.5 (1.8–3.7) 0.12
Notes: Continuous data presented as median (with range), and categorical data presented as percentage. Mean values of left and right eye used for patients with history of 
no or bilateral ON. Values of eye with ON were used for patients with history of unilateral ON. *Statistically significant (P,0.05).
Abbreviations: CRT, central retinal thickness; ETDRS, Early Treatment Diabetic Retinopathy Study; MS, multiple sclerosis; ON, optic neuritis; RNFL, retinal nerve fiber layer.
Table 2 Differences between eyes in patients with history of self-reported unilateral On
Eye with history of ON P-value
number 20
age (years) 47.1 (39.0–62.8)
sex (% male) 40.0
Time since onset of Ms (years) 12 (9–15)
Yes No
Visual acuity (eTDrs letters) 87 (63–93) 88 (58–97) 0.82
ishihara (number of errors) 1 (0–16) 1 (0–16) 0.57
intraocular pressure (mmhg) 15 (7–26) 15 (9–23) 0.26
CrT (µm) 226 (199–274) 225 (203–266) 0.61
rnFl
superior (µm) 110 (74–124) 109 (85–133) 0.20
inferior (µm) 109 (73–131) 115 (87–143) 0.04*
Temporal (µm) 56 (32–84) 62 (41–88) 0.30
nasal (µm) 81 (54–101) 87 (44–113) 0.31
Mean (µm) 87 (61–105) 93 (67–112) 0.06
CrT/rnFlmean ratio 2.7 (2.0–3.8) 2.4 (1.9–3.7) 0.04*
Notes: Data were only included for patients with unilateral On. We excluded all patients with 1) no On in either eye, 2) bilateral On, and 3) uncertainty of lateralization 
of ON. Continuous data presented as median (with range), and categorical data presented as percentage. *Statistically significant (P,0.05).
Abbreviations: CRT, central retinal thickness; ETDRS, Early Treatment Diabetic Retinopathy Study; MS, multiple sclerosis; ON, optic neuritis; RNFL, retinal nerve fiber layer.
 
Cl
in
ica
l O
ph
th
al
m
ol
og
y 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
6.
87
.1
74
 o
n 
09
-S
ep
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Ophthalmology 2017:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1522
andersen et al
OR 1.79 [95% CI 1.06–3.04] per 10 µm decrement in RNFL 
thickness, respectively) (Table 3). In a model adjusted for 
age and sex, this was still statistically significant for inferior 
and temporal RNFL (OR 1.56 [95% CI 1.01–2.41] and 1.74 
[95% CI 1.10–2.77] per 10 µm decrement in RNFL thick-
ness, respectively).
Discussion
In the present study, we demonstrated long-term structural 
changes in MS patients with a history of ON. Even though 
patients with ON, in general, did not have any functional 
loss of vision, it still was possible to demonstrate RNFL 
thinning with OCT.
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Figure 1 OCT with color photo and thickness maps.
Notes: (A) an eye which had never had On and with normal thickness of the rnFl around the optic disc. Visual acuity was 89 eTDrs letters. (B) an eye with a history 
of On. Visual acuity was 83 eTDrs letters, and there was substantial temporal rnFl loss (red) and a tendency toward inferior rnFl loss (yellow). numbers indicate rnFl 
as given in µm.
Abbreviations: ETDRS, Early Treatment Diabetic Retinopathy Study; OCT, optical coherence tomography; ON, optic neuritis; RNFL, retinal nerve fiber layer.
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Other studies have confirmed that patients with ON, in 
general, do not have persistent functional loss of vision. 
Beck et al20 demonstrated a normal visual acuity in 74% of 
319 patients after a history of ON 9.9–13.7 years earlier. This 
illustrates that the optic nerve is often functional despite the 
atrophic changes detected in the RNFL.
The interpretation from OCT studies in MS is challeng-
ing, since a large number of OCT devices from different 
generations are being used and measurements from different 
devices are not interchangeable.21–24 This is partly due to dif-
ferent normative databases and software algorithms among 
the machines. The Topcon software measures the macular 
thickness between the internal limiting membrane (ILM) 
and the top of the retinal pigment epithelium (RPE), whereas 
the Heidelberg software measures between the ILM and 
the bottom of the RPE. The inter device variation between 
different TD-OCT and SD-OCT varies from clinically insig-
nificant 2 µm (about axial resolution of SD-OCT) to 14 µm.13 
Although our one-center study had a single trained investiga-
tor performing all scans on the same SD-OCT machine, it is 
still difficult to compare our results with other studies.
Since Parisi et al12 demonstrated temporal and mean 
RNFL loss in eyes with ON caused by MS, numerous other 
studies using TD-OCT in MS emerged. In a meta-analysis 
including 27 studies with a total of 4,199 eyes, there was a 
mean reduction in RNFL of 14.6 µm in the eyes with ON 
caused by MS compared to the fellow eyes.25 Costello et al18 
demonstrated that about 75% of ON eyes had a 10–40 µm loss 
in RNFL 3–6 months after ON and, furthermore, identified 
a threshold value of 75 µm below which decreased visual 
function was seen. Since mean RNFL in healthy controls 
on TD-OCT is 105 µm, a decrease to 75 µm is substan-
tial and more than expected with normal aging (0.017% 
RNFL loss/year).
Studies by SD-OCT have demonstrated similar findings 
of reduced mean RNFL in MS-ON eyes compared to MS 
non-ON eyes.13,14,16 In this study, although not statistically 
significant, there was a trend toward mean RNFL thinning 
in MS-ON eyes compared with fellow eye (P=0.06) and in 
MS-ON compared with MS non-ON (P=0.07). Monteiro 
et al10 also found a trend toward mean RNFL loss in MS-ON 
eyes compared to MS non-ON eyes as well as sectorial loss 
in the temporal and superotemporal sector.
We found decreased RNFL in the inferior and temporal 
quadrants associated with previous ON. There was also a 
trend toward a higher risk of previous ON with mean RNFL 
loss, but this was not statistically significant when adjusted 
for age and sex. In consistency with our study, Khanifar et al16 
found a significant elevated risk of previous ON for patients 
with RNFL loss in the temporal and inferior sectors as well 
as for those with lower mean RNFL. This might be explained 
by certain retinal areas (ie, the papillomacular bundle in the 
temporal part of the peripapillary RNFL scan) being more 
susceptible to the temporary distress induced by ON. This 
may lead to retinal neurodegeneration despite unaffected 
functional visual outcome.
CRT is a measurement of the overall foveal thickness, 
which includes the internal limiting membrane, the outer 
plexiform layer, the outer nuclear layer, and the retinal 
cones. While the foveal structure is closely related to the 
visual acuity, peripapillary measurements of the RNFL are a 
more global measurement of the retinal ganglion cell axons. 
In order to combine the evaluation of the retinal structure at 
different parts, we developed and evaluated the OCT-derived 
composite end point of the CRT/RNFL
mean
 ratio. Such end 
points have also been tested in diseases such as glaucoma, 
where it has been demonstrated that regional ganglion cell 
layer/inner nuclear layer measures performed just as well 
as regional RNFL outcomes.26 For patients with a history of 
unilateral ON in our study, there was no difference between 
the eyes regarding CRT or mean RNFL. However, the CRT/
RNFL
mean
 ratio was higher in the eye that had ON. It is dif-
ficult to say if this was primarily driven by a higher CRT or 
a lower RNFL. In other neurodegenerative diseases such as 
diabetic retinopathy, there is a general association between 
retinal atrophy and disease activity,27 even though some 
studies have indicated increased retinal thickness in some 
patients.28 In our study, CRT/RNFL
mean
 ratio was different 
between the affected and non-affected eyes, while patients 
with and without a history of ON did not differ. Hence, we 
cannot conclude at this stage if CRT/RNFL
mean
 ratio could 
be a potential biomarker for retinal axonal degeneration or 
if it was an incidental finding.
Our study was strengthened by the use of high-resolution 
SD-OCT in a large, well-defined cohort of patients with 
long-term MS. On the other hand, the diagnosis of ON 
was self-reported, and even if we excluded a few patients, 
Table 3 risk of On per 10 µm decrement in rnFl thickness
RNFL Decrement OR (95% CI)
Unadjusted Age- and sex-adjusted
inferior -10 µm 1.63 (1.09–2.46)* 1.56 (1.01–2.41)*
Temporal -10 µm 1.79 (1.39–2.80)* 1.74 (1.10–2.77)*
Mean -10 µm 1.79 (1.06–3.04)* 1.70 (0.98–2.95)
Notes: Or (95% Ci) of having a history of On according to rnFl thickness in 
unadjusted model and model adjusted for age and sex. rnFlmean calculated as mean 
of rnFl thickness in superior, inferior, temporal, and nasal scan. *statistically 
significant (P,0.05).
Abbreviations: ON, optic neuritis; RNFL, retinal nerve fiber layer; OR, odds ratio; 
CI, confidence interval.
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who were not able to give a positive history, the study was 
still limited by the retrospective design and potential recall 
bias. In addition, we did not have available visual evoked 
potentials (VEPs). However, VEPs may not be able to detect 
changes after ON, ie, normal VEP does not exclude the pos-
sibility of a previous ON.29
Conclusion
In a long-term follow-up study, we demonstrated structural, 
but not functional, visual changes in patients with ON during 
the course of MS. RNFL thinning in the inferior or temporal 
sector were independently associated with ON. Upcoming 
studies should address these sectorial differences and evalu-
ate the use of composite structural end points.
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